Brokerages Set Syros Pharmaceuticals, Inc. (NASDAQ:SYRS) Target Price at $3.33
Shares of Syros Pharmaceuticals, Inc. (NASDAQ:SYRS – Get Free Report) have been given a consensus recommendation of “Hold” by the five ratings firms that are presently covering the firm, Marketbeat.com reports. Four research analysts have rated the stock with a hold recommendation and one has issued a buy recommendation on the company. The average 1 […]
Shares of Syros Pharmaceuticals, Inc. (NASDAQ:SYRS – Get Free Report) have been given a consensus recommendation of “Hold” by the five ratings firms that are presently covering the firm, Marketbeat.com reports. Four research analysts have rated the stock with a hold recommendation and one has issued a buy recommendation on the company. The average 1 […]
